Table 1 Meta analyses of slit randomized controlled trials
From: Recommendations for appropriate sublingual immunotherapy clinical trials
Author | Population | Disease* | Active/Placebo | SMD** | Heterogeneity I2 |
|---|---|---|---|---|---|
Wilson et al. [7] | Adults + Children | R | 484/475 | -0.42 | 73% |
Penagos et al. [10] | Children < 18 y | R | 245/239 | -0.56 | 81% |
Calamita et al. [9] | Adults + children | A | 150/153 | -0.38 | 64% |
Penagos et al. [11] | Children < 18 y | A | 232/209 | -1.14 | 92% |
Compalati et al. [13] | Adults + children only mite | RAC | 194/188 | -0.95 | 92% |
Di Bona et al. [14] | Adults + children only grass | RAC | 1518/1453 | -0.32 | 56% |
Radulovic et al. [8] | Adults + children | R | 2333/2256 | -0.49 | 81% |
Calderon et al. [12] | Adults + children | C | 1725/1674 | -0.41 | 59% |